Flucinolone acetonide    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
56Behcet disease1

56. Behcet disease    [ 68 clinical trials,   87 drugs,   (DrugBank: 31 drugs),   36 drug target genes,   113 drug target pathways]
Searched query = "Behcet disease", "Behçet disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 68 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00720928
(ClinicalTrials.gov)
July 200818/7/2008Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's DiseaseA Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's DiseaseOcular Behcet's Disease,;Non-Infectious Uveitis;Refractory UveitisDrug: flucinolone acetonideAsan Medical CenterSamsung Medical Center;Seoul National University Hospital;Kyunghee University Medical CenterRecruiting18 YearsN/ABoth15Phase 4Korea, Republic of